BAK1 Produkte
(BCL2-Antagonist/killer 1 (BAK1))
Kategorien
antibodies-online.com steht für hochwertige Forschungsprodukte. Suchen, finden und bestellen Sie Tools mit umfangreichen Validierungsdaten, Bildern, Referenzen. Unser wissenschaftlicher Kundenservice steht Ihnen jederzeit zur Verfügung, wenn Sie Fragen zur Auswahl oder Anwendung unserer Produkte haben.
Ausgewählte BAK1 Kategorien
BAK1 Antikörper
High quality antibodies with extensive validation data.
BAK1 ELISA Kits
Reliable ELISA kits for a wide range of species.
BAK1 Proteine
Proteins for various applications incl. WB, ELISA, IF etc.
Empfohlene BAK1 Antikörper
- (6)
- (8)
- (2)
- (10)
Empfohlene BAK1 ELISA Kits
- (1)
- (1)
- (1)
Empfohlene BAK1 Proteine
- (1)
- (1)
- (1)
Neueste Publikationen zu unseren BAK1 Produkten
: "YWHAZ amplification/overexpression defines aggressive bladder cancer and contributes to chemo-/radio-resistance by suppressing caspase-mediated apoptosis." in: The Journal of pathology, (2019) (PubMed).: "Copper induces oxidative stress and apoptosis through mitochondria-mediated pathway in chicken hepatocytes." in: Toxicology in vitro : an international journal published in association with BIBRA, Vol. 54, pp. 310-316, (2019) (PubMed).
: "MicroRNA-29c Correlates with Neuroprotection Induced by FNS by Targeting Both Birc2 and Bak1 in Rat Brain after Stroke." in: CNS neuroscience & therapeutics, Vol. 21, Issue 6, pp. 496-503, (2016) (PubMed).
: "Paraquat Induces Cell Death Through Impairing Mitochondrial Membrane Permeability." in: Molecular neurobiology, (2015) (PubMed).
: "Ovatodiolide sensitizes aggressive breast cancer cells to doxorubicin, eliminates their cancer stem cell-like phenotype, and reduces doxorubicin-associated toxicity." in: Cancer letters, Vol. 364, Issue 2, pp. 125-34, (2015) (PubMed).
: "Notch4 Signaling Confers Susceptibility to TRAIL-Induced Apoptosis in Breast Cancer Cells." in: Journal of cellular biochemistry, Vol. 116, Issue 7, pp. 1371-80, (2015) (PubMed).
: "Regulation of cell transformation by Rb-controlled redox homeostasis." in: PLoS ONE, Vol. 9, Issue 7, pp. e102582, (2014) (PubMed).
: "The C-terminal domain (CTD) in linker histones antagonizes anti-apoptotic proteins to modulate apoptotic outcomes at the mitochondrion." in: Cell death & disease, Vol. 5, pp. e1058, (2014) (PubMed).
: "Systems analysis of BCL2 protein family interactions establishes a model to predict responses to chemotherapy." in: Cancer research, Vol. 73, Issue 2, pp. 519-28, (2013) (PubMed).
: "Disruption of the VDAC2-Bak interaction by Bcl-x(S) mediates efficient induction of apoptosis in melanoma cells." in: Cell death and differentiation, Vol. 19, Issue 12, pp. 1928-38, (2012) (PubMed).
Synonyme und alternative Namen zu BAK1
BCL2 antagonist/killer 1 (BAK1), BCL2-antagonist/killer 1 (Bak1), BCL2 antagonist/killer 1 (Bak1), BCL2 antagonist/killer 1 L homeolog (bak1.L), BAK, Bak, bak, BAK-LIKE, Bak1, bak1, BCL2L7, CDN1, N-Bak, N-BAK1Bezeichner auf Proteinebene für BAK1
- BCL2-like 7 protein
- apoptosis regulator BAK
- bcl-2 homologous antagonist/killer
- bcl-2-like protein 7
- bcl2-L-7
- pro-apoptotic protein BAK
- Bcl2 homologous antagonist/killer
- Bcl-2-like 7
- BCL2 antagonist/killer 1 L homeolog